Progress in understanding melanoma propagation

Yazar: Shackleton, Mark, Quintana, Elsa
Baskı/Yayın Bilgisi 2010

Personalised surveillance after treatment for high-risk cancer

Yazar: Guo, Christina, Lewin, Jeremy, Shackleton, Mark
Yayımlandı Oncotarget (2019)

An update on adjuvant systemic therapies in melanoma

Yazar: Samuel, Evangeline, Moore, Maggie, Voskoboynik, Mark, Shackleton, Mark, Haydon, Andrew
Yayımlandı Melanoma Manag (2019)

Efficient tumor formation by single human melanoma cells

Yazar: Quintana, Elsa, Shackleton, Mark, Sabel, Michael S., Fullen, Douglas R., Johnson, Timothy M., Morrison, Sean J.
Baskı/Yayın Bilgisi 2008

Bevacizumab as a steroid‐sparing agent during immunotherapy for melanoma brain metastases: A case series

Yazar: Banks, Patricia D., Lasocki, Arian, Lau, Peter K. H., Sandhu, Shahneen, McArthur, Grant, Shackleton, Mark
Yayımlandı Health Sci Rep (2019)

Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized

Yazar: Quintana, Elsa, Shackleton, Mark, Foster, Hannah R., Fullen, Douglas R., Sabel, Michael S., Johnson, Timothy M., Morrison, Sean J.
Baskı/Yayın Bilgisi 2010

Human melanoma metastasis in NSG mice correlates with clinical outcome in patients

Yazar: Quintana, Elsa, Piskounova, Elena, Shackleton, Mark, Weinberg, Daniel, Eskiocak, Ugur, Fullen, Douglas R., Johnson, Timothy M., Morrison, Sean J.
Yayımlandı Sci Transl Med (2012)

Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped reads

Yazar: Schröder, Jan, Hsu, Arthur, Boyle, Samantha E., Macintyre, Geoff, Cmero, Marek, Tothill, Richard W., Johnstone, Ricky W., Shackleton, Mark, Papenfuss, Anthony T.
Baskı/Yayın Bilgisi 2014

Physiological Levels of Pik3ca (H1047R) Mutation in the Mouse Mammary Gland Results in Ductal Hyperplasia and Formation of ERα-Positive Tumors

Yazar: Tikoo, Anjali, Roh, Vincent, Montgomery, Karen G., Ivetac, Ivan, Waring, Paul, Pelzer, Rebecca, Hare, Lauren, Shackleton, Mark, Humbert, Patrick, Phillips, Wayne A.
Baskı/Yayın Bilgisi 2012

Implementation of patient-reported outcome measures and patient-reported experience measures in melanoma clinical quality registries: a systematic review

Yazar: Blood, Zachary, Tran, Anh, Caleo, Lauren, Saw, Robyn, Dieng, Mbathio, Shackleton, Mark, Soyer, H Peter, Arnold, Chris, Mann, Graham J, Morton, Rachael L
Yayımlandı BMJ Open (2021)

HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cells

Yazar: Carter, Christoph C., McNamara, Lucy A., Onafuwa-Nuga, Adewunmi, Shackleton, Mark, Riddell, James, Bixby, Dale, Savona, Michael R., Morrison, Sean J., Collins, Kathleen L.
Baskı/Yayın Bilgisi 2011

Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma

Yazar: Eskiocak, Ugur, Ramesh, Vijayashree, Gill, Jennifer G., Zhao, Zhiyu, Yuan, Stacy W., Wang, Meng, Vandergriff, Travis, Shackleton, Mark, Quintana, Elsa, Johnson, Timothy M., DeBerardinis, Ralph J., Morrison, Sean J.
Yayımlandı Nat Commun (2016)

Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma

Yazar: Eskiocak, Ugur, Ramesh, Vijayashree, Gill, Jennifer G., Zhao, Zhiyu, Yuan, Stacy W., Wang, Meng, Vandergriff, Travis, Shackleton, Mark, Quintana, Elsa, Frankel, Arthur E., Johnson, Timothy M., DeBerardinis, Ralph J., Morrison, Sean J.
Yayımlandı Nat Commun (2016)

Long-term outcome in BRAF(V600E) melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression

Yazar: Puzanov, Igor, Amaravadi, Ravi K., McArthur, Grant A., Flaherty, Keith T., Chapman, Paul B., Sosman, Jeffrey A., Ribas, Antoni, Shackleton, Mark, Hwu, Patrick, Chmielowski, Bartosz, Nolop, Keith B., Lin, Paul S., Kim, Kevin B.
Yayımlandı Eur J Cancer (2015)

Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome

Yazar: Tan, Lih Yin, Mintoff, Chris, Johan, M. Zahied, Ebert, Brenton W., Fedele, Clare, Zhang, You Fang, Szeto, Pacman, Sheppard, Karen E., McArthur, Grant A., Foster-Smith, Erwin, Ruszkiewicz, Andrew, Brown, Michael P., Bonder, Claudine S., Shackleton, Mark, Ebert, Lisa M.
Yayımlandı Oncotarget (2016)

Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma

Yazar: Lynch, Fiona A, Katona, Lynda, Jefford, Michael, Smith, Allan Ben, Shaw, Joanne, Dhillon, Haryana M, Ellen, Steve, Phipps-Nelson, Jo, Lai-Kwon, Julia, Milne, Donna, Russell, Lahiru, Dax, Victoria, Diggens, Justine, Kent, Holly, Button-Sloan, Alison, Elliott, Jane, Shackleton, Mark, Burridge, Hayley, Ftanou, Maria
Yayımlandı J Clin Med (2020)

Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi

Yazar: Robertson, Susan J., Orme, Lisa, Teixeira, Rodrigo, Shamassi, Maryam, Newell, Felicity, Patch, Ann-Marie, Yeh, Iwei, Gard, Grace, Wilmott, James, Jackett, Louise, LeBoit, Philip, Fellowes, Andrew, MacArthur, Grant, Fox, Stephen, Hayward, Nicholas K., Bastian, Boris, Scolyer, Richard, Waddell, Nicola, Penington, Anthony, Shackleton, Mark
Yayımlandı JAMA Dermatol (2021)

MDM4 is a key therapeutic target in cutaneous melanoma

Yazar: Gembarska, Agnieszka, Luciani, Flavie, Fedele, Clare, Russell, Elisabeth A, Dewaele, Michael, Villar, Stéphanie, Zwolinska, Aleksandra, Haupt, Sue, de Lange, Job, Yip, Dana, Goydos, James, Haigh, Jody J, Haupt, Ygal, Larue, Lionel, Jochemsen, Aart, Shi, Hubing, Moriceau, Gatien, Lo, Roger S, Ghanem, Ghanem, Shackleton, Mark, Bernal, Federico, Marine, Jean-Christophe
Baskı/Yayın Bilgisi 2012

A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis

Yazar: Ebert, Lisa M., Tan, Lih Y., Johan, M. Zahied, Min, Kay Khine Myo, Cockshell, Michaelia P., Parham, Kate A., Betterman, Kelly L., Szeto, Paceman, Boyle, Samantha, Silva, Lokugan, Peng, Angela, Zhang, YouFang, Ruszkiewicz, Andrew, Zannettino, Andrew C. W., Gronthos, Stan, Koblar, Simon, Harvey, Natasha L., Lopez, Angel F., Shackleton, Mark, Bonder, Claudine S.
Yayımlandı Angiogenesis (2016)

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

Yazar: Davis, Ian D., Chen, Weisan, Jackson, Heather, Parente, Phillip, Shackleton, Mark, Hopkins, Wendie, Chen, Qiyuan, Dimopoulos, Nektaria, Luke, Tina, Murphy, Roger, Scott, Andrew M., Maraskovsky, Eugene, McArthur, Grant, MacGregor, Duncan, Sturrock, Sue, Tai, Tsin Yee, Green, Simon, Cuthbertson, Andrew, Maher, Darryl, Miloradovic, Lena, Mitchell, Susan V., Ritter, Gerd, Jungbluth, Achim A., Chen, Yao-Tseng, Gnjatic, Sacha, Hoffman, Eric W., Old, Lloyd J., Cebon, Jonathan S.
Baskı/Yayın Bilgisi 2004